Skip to main content

Bupropion News

Prolonged Antidepressant Treatment No Benefit in Bipolar I Disorder

THURSDAY, Aug. 3, 2023 – For patients with bipolar I disorder who had recently had remission of a depressive episode, adjunctive treatment with escitalopram or bupropion XL that continues for 52...

Adaptation to Pharmacotherapy Does Not Up Smoking Cessation in Black Adults

TUESDAY, June 27, 2023 – For Black adults who smoke, adaptation to varenicline and/or bupropion plus nicotine patch (NP) does not improve abstinence rates compared with NP monotherapy, according to...

FDA Medwatch Alert: Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised

ISSUE: Based on an FDA review of a large clinical trial that FDA required the drug companies to conduct, FDA determined the risk of serious side effects on mood, behavior, or thinking with the...

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

September 10, 2014 – The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Attention-Deficit Hyperactivity Disorder (ADHD), Weight Loss (Obesity / Overweight), Major Depressive Disorder, Anxiety, Bipolar Disorder, Borderline Personality Disorder, Depression, Smoking Cessation, Seasonal Affective Disorder, view more... Migraine Prevention, Migraine Prophylaxis, Panic Disorder, Dysthymia, Premenstrual Dysphoric Disorder, Sexual Dysfunction, SSRI Induced

Related drug support groups

Wellbutrin, Wellbutrin XL, Wellbutrin SR

Bupropion patient information at Drugs.com